Patellofemoral Pain Syndrome Is Associated With Chronic Disease and Allergies in 60 997 Distance Runner Race Entrants: SAFER XXX Study.
Journal
Clinical journal of sport medicine : official journal of the Canadian Academy of Sport Medicine
ISSN: 1536-3724
Titre abrégé: Clin J Sport Med
Pays: United States
ID NLM: 9103300
Informations de publication
Date de publication:
01 11 2023
01 11 2023
Historique:
received:
13
07
2022
accepted:
22
05
2023
medline:
3
11
2023
pubmed:
30
6
2023
entrez:
30
6
2023
Statut:
ppublish
Résumé
Patellofemoral pain syndrome (PFPS) is a common running-related injury. Independent risk factors associated with PFPS have not been described in a large cohort of distance runners. Descriptive, cross-sectional study. 21.1 and 56 km Two Oceans Marathon races (2012-2015). 60 997 race entrants. Participants completed a compulsory prerace medical screening questionnaire (history of PFPS in the past 12 months, n = 362; no injury history, n = 60 635). Selected risk factors associated with a history of PFPS were explored using univariate & multivariate analyses: demographics, training/running variables, history of chronic diseases (composite chronic disease score), and any allergy. Prevalence ratios (PRs, 95% confidence intervals). Risk factors associated with PFPS (univariate analysis) were increased years of recreational running (PR = 1.09; P = 0.0107), older age (>50 years), and chronic diseases (PR > 2): gastrointestinal disease (PR = 5.06; P < 0.0001), cardiovascular disease (CVD) (PR = 3.28; P < 0.0001), nervous system/psychiatric disease (PR = 3.04; P < 0.0001), cancer (PR = 2.83; P = 0.0005), risk factors for CVD (PR = 2.42; P < 0.0001), symptoms of CVD (PR = 2.38; P = 0.0397), and respiratory disease (PR = 2.00; P < 0.0001). Independent risk factors (multivariate analysis) associated with PFPS (adjusted for age, sex, and race distance) were a higher chronic disease composite score (PR = 2.68 increased risk for every 2 additional chronic diseases; P < 0.0001) and a history of allergies (PR = 2.33; P < 0.0001). Novel independent risk factors associated with PFPS in distance runners are a history of multiple chronic diseases and a history of allergies. Identification of chronic diseases and allergies should be considered as part of the clinical assessment of a runner presenting with a history of PFPS.
Identifiants
pubmed: 37389463
doi: 10.1097/JSM.0000000000001166
pii: 00042752-202311000-00005
doi:
Types de publication
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Pagination
603-610Informations de copyright
Copyright © 2023 Wolters Kluwer Health, Inc. All rights reserved.
Déclaration de conflit d'intérêts
The authors report no conflicts of interest.
Références
Pedersen BK, Saltin B. Exercise as medicine–evidence for prescribing exercise as therapy in 26 different chronic diseases. Scand J Med Sci Sports. 2015;25:1–72.
Global Action Plan on Physical Activity 2018–2030: More Active People for a Healthier World. Geneva: World Health Organisation; 2018; Available at: https://www.who.int/publications/i/item/9789241514187 . Accessed February 3, 2022.
Murphy N, Lane A, Bauman A. Leveraging mass participation events for sustainable health legacy. Leis Stud. 2015;34:758–766.
Nielsen RO, Buist I, Sørensen H, et al. Training errors and running related injuries: a systematic review. Int J Sports Phys Ther. 2012;7:58–75.
Fredericson M, Misra AK. Epidemiology and aetiology of marathon running injuries. Sports Med. 2007;37:437–439.
Mullaney MJ, Fukunaga T. Current concepts and treatment of patellofemoral compressive issues. Int J Sports Phys Ther. 2016;11:891–902.
Crossley KM, Stefanik JJ, Selfe J, et al. 2016 Patellofemoral pain consensus statement from the 4th International Patellofemoral Pain Research Retreat, Manchester. Part 1: terminology, definitions, clinical examination, natural history, patellofemoral osteoarthritis and patient-reported outcome measures. Br J Sports Med. 2016;50:839–843.
Halabchi F, Abolhasani M, Mirshahi M, et al. Patellofemoral pain in athletes: clinical perspectives. Open Access J Sports Med. 2017;8:189–203.
Kunene SH, Ramklass S, Taukobong NP. Anterior knee pain and its intrinsic risk factors among runners in under-resourced communities in Ekurhuleni, Gauteng. South Afr J Physiother. 2018;74:452.
Francis P, Whatman C, Sheerin K, et al. The proportion of lower limb running injuries by gender, anatomical location and specific pathology: a systematic review. J Sports Sci Med. 2019;18:21–31.
Fredette MA, Roy J-S, Esculier J-FO, et al. Most military runners report recent changes in running parameters before lower limb injury onset. Mil Med. 2021;186:e1140–e1148.
Bonacci J, Hall M, Fox A, et al. The influence of cadence and shoes on patellofemoral joint kinetics in runners with patellofemoral pain. J Sci Med Sport. 2018;21:574–578.
Esculier JF, Roy JS, Bouyer LJ. Lower limb control and strength in runners with and without patellofemoral pain syndrome. Gait Posture. 2015;41:813–819.
Noehren B, Pohl MB, Sanchez Z, et al. Proximal and distal kinematics in female runners with patellofemoral pain. Clin Biomech. 2012;27:366–371.
Viljoen CT, Sewry N, Schwellnus MP, et al. Independent risk factors predicting gradual onset injury in 2824 trail running race entrants: SAFER XVIII study. Wilderness Environ Med. 2021;32:293–301.
Mokwena PL, Schwellnus MP, Jansen van Rensburg A, et al. Chronic disease, allergies, and increased years of running are risk factors predicting Gradual Onset Running-Related Injuries in ultramarathon runners—SAFER XIX study in 29 585 race entrants. Clin J Sport Med. 2022;32:e422–429.
Boer P-H, Schwellnus MP, Jordaan E. Chronic diseases and allergies are risk factors predictive of a history of Medial Tibial Stress Syndrome (MTSS) in distance runners: SAFER study XXIV. Phys Sportsmed. 2022;51:166–174.
Swanevelder S, Sewry N, Schwellnus M, et al. Predictors of multiple injuries in individual distance runners: a retrospective study of 75,401 entrants in 4 annual races–SAFER XX. J Sport Health Sci. 2022;11:339–346.
Schwellnus M, Derman W. The quest to reduce the risk of adverse medical events in exercising individuals: introducing the SAFER (Strategies to reduce Adverse medical events for the ExerciseR) studies. Br J Sports Med. 2014;48:869–870.
Schwabe K, Schwellnus M, Swanevelder S, et al. Leisure athletes at risk of medical complications: outcomes of pre-participation screening among 15,778 endurance runners-SAFER VII. Phys Sportsmed. 2018;46:405–413.
Schwellnus M, Swanevelder S, Derman W, et al. Prerace medical screening and education reduce medical encounters in distance road races: SAFER VIII study in 153 208 race starters. Br J Sports Med. 2019;53:634–639.
Perk J, De Backer G, Gohlke H, et al. European Guidelines on Cardiovascular Disease Prevention in Clinical Practice (version 2012): the fifth joint task force of the European society of cardiology and other Societies on cardiovascular disease prevention in clinical practice (constituted by representatives of nine societies and by invited experts). Eur Heart J. 2012;33:1635–1701.
Corrado DSC, Schmied C, Basso C, et al. Risk of sports: do we need a pre-participation screening for competitive and leisure athletes? Eur Heart J. 2011;32:934–944.
Bahr R, Clarsen B, Derman W, et al. International Olympic Committee consensus statement: methods for recording and reporting of epidemiological data on injury and illness in sports 2020 (including the STROBE extension for sports injury and illness surveillance (STROBE-SIIS)). Orthopaedic J Sports Med. 2020;8:1–33.
Viljoen CT, Janse van Rensburg DC, Verhagen E, et al. Epidemiology of injury and illness among trail runners: a systematic review. Sports Med. 2021;51:917–943.
Nielsen RO, Simonsen NS, Casals M, et al. Methods matter and the ‘too much, too soon’ theory (part 2): what is the goal of your sports injury research? Are you describing, predicting or drawing a causal inference? Br J Sports Med. 2020;54:1307–1309.
Du Toit F, Schwellnus M, Wood P, et al. History of chronic disease is a novel intrinsic risk factor associated with gradual onset injuries in recreational road cyclists: a cross-sectional study in 21,824 cyclists-SAFER XIV. Phys Ther Sport. 2020;46:137–144.
Nichols AEC, Oh I, Loiselle AE. Effects of Type II diabetes mellitus on tendon homeostasis and healing. J Orthop Res. 2020;38:13–22.
Burne G, Mansfield M, Gaida JE, et al. Is there an association between metabolic syndrome and rotator cuff-related shoulder pain? A systematic review. BMJ Open Sport Exerc Med. 2019;5:e000544.
Abate M, Schiavone C, Salini V, et al. Occurrence of tendon pathologies in metabolic disorders. Rheumatology (Oxford). 2013;52:599–608.
Zampieri S, Valente M, Adami N, et al. Polymyositis, dermatomyositis and malignancy: a further intriguing link. Autoimmun Rev. 2010;9:449–453.
Ungprasert P, Bethina NK, Jones CH. Malignancy and idiopathic inflammatory myopathies. North Am J Med Sci. 2013;5:569–572.
Thong BKS, Ima-Nirwana S, Chin K-Y. Proton pump inhibitors and fracture risk: a review of current evidence and mechanisms involved. Int J Environ Res Public Health. 2019;16:1571.
Levin OS, Polunina AG, Demyanova MA, et al. Steroid myopathy in patients with chronic respiratory diseases. J Neurol Sci. 2014;338:96–101.
Mammen AL. Statin-associated autoimmune myopathy. N Engl J Med. 2016;374:664–669.
Marie I, Delafenêtre H, Massy N, et al. Tendinous disorders attributed to statins: a study on ninety‐six spontaneous reports in the period 1990–2005 and review of the literature. Arthritis Rheum. 2008;59:367–372.
Barnes PJ. Pathophysiology of allergic inflammation. Immunol Rev. 2011;242:31–50.
Waryasz GR, McDermott AY. Patellofemoral pain syndrome (PFPS): a systematic review of anatomy and potential risk factors. Dynamic Med. 2008;7:9.
Van der Stede T, Blancquaert L, Stassen F, et al. Histamine H1 and H2 receptors are essential transducers of the integrative exercise training response in humans. Sci Adv. 2021;7:eabf2856.
Ely MR, Sieck DC, Mangum JE, et al. Histamine-receptor antagonists slow 10-km cycling performance in competitive cyclists. Med Sci Sports Exerc. 2019;51:1487–1497.
Luttrell MJ, Halliwill JR. The intriguing role of histamine in exercise responses. Exerc Sport Sci Rev. 2017;45:16–23.